Phosphorylation and transcriptional activity regulation of retinoid-related orphan receptor alpha 1 by protein kinases C

Journal of Neurochemistry

Volumn 104, Issue 5, 2008, Pages 1321-1332

  Duplus, Eric ^a,b   Gras, Christelle ^a   Soubeyre, Vanessa ^a   Vodjdani, Guilan ^a   Lemaigre Dubreuil, Yolande ^a   Brugg, Bernard ^a  

^a SORBONNE UNIVERSITÉ   (France)

^b Université Pierre et Marie Curie   (France)

Author keywords

Cortical neurons; COS 7 cells; Nuclear receptor; Phorbol ester; Protein kinase C; Retinoid related orphan receptor

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN KINASE; RETINOID DERIVATIVE; RETINOID RELATED ORPHAN RECEPTOR ALPHA 1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CELL DEATH; CELL SURVIVAL; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; NERVE CELL; NONHUMAN; NUCLEAR REACTOR; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

ANIMALS; CATTLE; CELLS, CULTURED; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; MICE; NEURONS; PHOSPHORYLATION; PROTEIN KINASE C; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANS-ACTIVATORS; TRANSCRIPTION, GENETIC;

MUS;

EID: 39749142102     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2007.05074.x     Document Type: Article

References (69)

1. Akita Y., Ohno S., Konno Y., Yano A. Suzuki K. (1990) Expression and properties of two distinct classes of the phorbol ester receptor family, four conventional protein kinase C types, and a novel protein kinase C. J. Biol. Chem. 265, 354 362.
2. Aschrafi A., Meindl N., Firla B., Brandes R. P. Steinhilber D. (2006) Intracellular localization of RORalpha is isoform and cell line-dependent. Biochim. Biophys. Acta 1763, 805 814.
3. Atkins G. B., Hu X., Guenther M. G., Rachez C., Freedman L. P. Lazar M. A. (1999) Coactivators for the orphan nuclear receptor RORalpha. Mol. Endocrinol. 13, 1550 1557.
4. Becker-Andre M., Andre E. DeLamarter J. F. (1993) Identification of nuclear receptor mRNAs by RT-PCR amplification of conserved zinc-finger motif sequences. Biochem. Biophys. Res. Commun. 194, 1371 1379.
5. Bennett B. L., Sasaki D. T., Murray B. W. et al. (2001) SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl Acad. Sci. USA 98, 13681 13686.
6. Boukhtouche F., Janmaat S., Vodjdani G., Gautheron V., Mallet J., Dusart I. Mariani J. (2006a) Retinoid-related orphan receptor alpha controls the early steps of Purkinje cell dendritic differentiation. J. Neurosci. 26, 1531 1538.
7. Boukhtouche F., Vodjdani G., Jarvis C. I., Bakouche J., Staels B., Mallet J., Mariani J., Lemaigre-Dubreuil Y. Brugg B. (2006b) Human retinoic acid receptor-related orphan receptor alpha1 over-expression protects neurones against oxidative stress-induced apoptosis. J. Neurochem. 96, 1778 1789.
8. Brkanac Z., Bylenok L., Fernandez M., Matsushita M., Lipe H., Wolff J., Nochlin D., Raskind W. H. Bird T. D. (2002) A new dominant spinocerebellar ataxia linked to chromosome 19q13.4-qter. Arch. Neurol. 59, 1291 1295.
9. Carlberg C., Hooft van Huijsduijnen R., Staple J. K., DeLamarter J. F. Becker-Andre M. (1994) RZRs, a new family of retinoid-related orphan receptors that function as both monomers and homodimers. Mol. Endocrinol. 8, 757 770.
10. Caston J., Delhaye-Bouchaud N. Mariani J. (1995) Motor behavior of heterozygous staggerer mutant (+/sg) versus normal (+/+) mice during aging. Behav. Brain Res. 72, 97 102.
11. Chen D. H., Brkanac Z., Verlinde C. L. et al. (2003) Missense mutations in the regulatory domain of PKC gamma: a new mechanism for dominant nonepisodic cerebellar ataxia. Am. J. Hum. Genet. 72, 839 849.
12. Delerive P., Monte D., Dubois G., Trottein F., Fruchart-Najib J., Mariani J., Fruchart J. C. Staels B. (2001) The orphan nuclear receptor ROR alpha is a negative regulator of the inflammatory response. EMBO Rep. 2, 42 48.
13. Doulazmi M., Frederic F., Capone F., Becker-Andre M., Delhaye-Bouchaud N. Mariani J. (2001) A comparative study of Purkinje cells in two RORalpha gene mutant mice: staggerer and RORalpha(-/-). Brain Res. Dev. Brain Res. 127, 165 174.
14. Duncia J. V., Santella III. J. B., Higley C. A. et al. (1998) MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorg. Med. Chem. Lett. 8, 2839 2844.
15. Dussault I., Fawcett D., Matthyssen A., Bader J. A. Giguere V. (1998) Orphan nuclear receptor ROR alpha-deficient mice display the cerebellar defects of staggerer. Mech. Dev. 70, 147 153.
16. Ebinu J. O., Bottorff D. A., Chan E. Y., Stang S. L., Dunn R. J. Stone J. C. (1998) RasGRP, a Ras guanyl nucleotide-releasing protein with calcium- and diacylglycerol-binding motifs. Science 280, 1082 1086.
17. Fahey M. C., Knight M. A., Shaw J. H., Gardner R. J., du Sart D., Lockhart P. J., Delatycki M. B., Gates P. C. Storey E. (2005) Spinocerebellar ataxia type 14: study of a family with an exon 5 mutation in the PRKCG gene. J. Neurol. Neurosurg. Psychiatry 76, 1720 1722.
18. Gallegos L. L., Kunkel M. T. Newton A. C. (2006) Targeting protein kinase C activity reporter to discrete intracellular regions reveals spatiotemporal differences in agonist-dependent signaling. J. Biol. Chem. 281, 30947 30956.
19. Ghoumari A. M., Wehrle R., De Zeeuw C. I., Sotelo C. Dusart I. (2002) Inhibition of protein kinase C prevents Purkinje cell death but does not affect axonal regeneration. J. Neurosci. 22, 3531 3542.
20. Giguere V. (1999) Orphan nuclear receptors: from gene to function. Endocr. Rev. 20, 689 725.
21. Giguere V., Tini M., Flock G., Ong E., Evans R. M. Otulakowski G. (1994) Isoform-specific amino-terminal domains dictate DNA-binding properties of ROR alpha, a novel family of orphan hormone nuclear receptors. Genes Dev. 8, 538 553.
22. Gopalakrishna R. Jaken S. (2000) Protein kinase C signaling and oxidative stress. Free Radic. Biol. Med. 28, 1349 1361.
23. Gras C., Herzog E., Bellenchi G. C., Bernard V., Ravassard P., Pohl M., Gasnier B., Giros B. El Mestikawy S. (2002) A third vesicular glutamate transporter expressed by cholinergic and serotoninergic neurons. J. Neurosci. 22, 5442 5451.
24. Gundlfinger A., Kapfhammer J. P., Kruse F., Leitges M. Metzger F. (2003) Different regulation of Purkinje cell dendritic development in cerebellar slice cultures by protein kinase C alpha and beta. J. Neurobiol. 57, 95 109.
25. Gutcher I., Webb P. R. Anderson N. G. (2003) The isoform-specific regulation of apoptosis by protein kinase C. Cell Mol. Life Sci. 60, 1061 1070.
26. Hadj-Sahraoui N., Frederic F., Zanjani H., Delhaye-Bouchaud N., Herrup K. Mariani J. (2001) Progressive atrophy of cerebellar Purkinje cell dendrites during aging of the heterozygous staggerer mouse (Rora(+/sg)). Brain Res. Dev. Brain Res. 126, 201 209.
27. Hamilton B. A., Frankel W. N., Kerrebrock A. W. et al. (1996) Disruption of the nuclear hormone receptor RORalpha in staggerer mice. Nature 379, 736 739.
28. Harding H. P., Atkins G. B., Jaffe A. B., Seo W. J. Lazar M. A. (1997) Transcriptional activation and repression by RORalpha, an orphan nuclear receptor required for cerebellar development. Mol. Endocrinol. 11, 1737 1746.
29. Herrup K. Mullen R. J. (1979) Staggerer chimeras: intrinsic nature of Purkinje cell defects and implications for normal cerebellar development. Brain Res. 178, 443 457.
30. Ino H. (2004) Immunohistochemical characterization of the orphan nuclear receptor ROR alpha in the mouse nervous system. J. Histochem. Cytochem. 52, 311 323.
31. Jarvis C. I., Staels B., Brugg B., Lemaigre-Dubreuil Y., Tedgui A. Mariani J. (2002) Age-related phenotypes in the staggerer mouse expand the RORalpha nuclear receptor's role beyond the cerebellum. Mol. Cell. Endocrinol. 186, 1 5.
32. Kallen J. A., Schlaeppi J. M., Bitsch F., Geisse S., Geiser M., Delhon I. Fournier B. (2002) X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha. Structure 10, 1697 1707.
33. 2+/calmodulin-dependent protein kinase IV. EMBO J. 19, 691 701.
34. Kapfhammer J. P. (2004) Cellular and molecular control of dendritic growth and development of cerebellar Purkinje cells. Prog. Histochem. Cytochem. 39, 131 182.
35. Kazanietz M. G. (2002) Novel 'nonkinase' phorbol ester receptors: the C1 domain connection. Mol. Pharmacol. 61, 759 767.
36. Klebe S., Durr A., Rentschler A. et al. (2005) New mutations in protein kinase C gamma associated with spinocerebellar ataxia type 14. Ann. Neurol. 58, 720 729.
37. Kolch W. (2005) Coordinating ERK/MAPK signalling through scaffolds and inhibitors. Nat. Rev. Mol. Cell Biol. 6, 827 837.
38. Lang W., Wang H., Ding L. Xiao L. (2004) Cooperation between PKC-alpha and PKC-epsilon in the regulation of JNK activation in human lung cancer cells. Cell. Signal. 16, 457 467.
39. Lechtken A., Hornig M., Werz O., Corvey N., Zundorf I., Dingermann T., Brandes R. Steinhilber D. (2007) Extracellular signal-regulated kinase-2 phosphorylates RORalpha4 in vitro. Biochem. Biophys. Res. Commun. 358, 890 896.
40. Linden D. J. Connor J. A. (1991) Participation of postsynaptic PKC in cerebellar long-term depression in culture. Science 254, 1656 1659.
41. Liu W. S. Heckman C. A. (1998) The sevenfold way of PKC regulation. Cell. Signal. 10, 529 542.
42. Lu Z. Xu S. (2006) ERK1/2 MAP kinases in cell survival and apoptosis. IUBMB Life 58, 621 631.
43. Maher P. (2001) How protein kinase C activation protects nerve cells from oxidative stress-induced cell death. J. Neurosci. 21, 2929 2938.
44. Marquardt B., Frith D. Stabel S. (1994) Signalling from TPA to MAP kinase requires protein kinase C, raf and MEK: reconstitution of the signalling pathway in vitro. Oncogene 9, 3213 3218.
45. Martelli A. M., Evangelisti C., Nyakern M. Manzoli F. A. (2006) Nuclear protein kinase C. Biochim. Biophys. Acta 1761, 542 551.
46. Martiny-Baron G., Kazanietz M. G., Mischak H., Blumberg P. M., Kochs G., Hug H., Marme D. Schachtele C. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J. Biol. Chem. 268, 9194 9197.
47. Matsui T., Sashihara S., Oh Y. Waxman S. G. (1995) An orphan nuclear receptor, mROR alpha, and its spatial expression in adult mouse brain. Brain Res. Mol. Brain Res. 33, 217 226.
48. Matysiak-Scholze U. Nehls M. (1997) The structural integrity of ROR alpha isoforms is mutated in staggerer mice: cerebellar coexpression of ROR alpha1 and ROR alpha4. Genomics 43, 78 84.
49. Mauro A., Ciccarelli C., De Cesaris P., Scoglio A., Bouche M., Molinaro M., Aquino A. Zani B. M. (2002) PKCalpha-mediated ERK JNK and p38 activation regulates the myogenic program in human rhabdomyosarcoma cells. J. Cell Sci. 115, 3587 3599.
50. Metzger F. Kapfhammer J. P. (2000) Protein kinase C activity modulates dendritic differentiation of rat Purkinje cells in cerebellar slice cultures. Eur. J. Neurosci. 12, 1993 2005.
51. Moraitis A. N., Giguere V. Thompson C. C. (2002) Novel mechanism of nuclear receptor co-repressor interaction dictated by activation function 2 helix determinants. Mol. Cell. Biol. 22, 6831 6841.
52. Nakagawa S., Watanabe M. Inoue Y. (1997) Prominent expression of nuclear hormone receptor ROR alpha in Purkinje cells from early development. Neurosci. Res. 28, 177 184.
53. Price M. O., McPhail L. C., Lambeth J. D., Han C. H., Knaus U. G. Dinauer M. C. (2002) Creation of a genetic system for analysis of the phagocyte respiratory burst: high-level reconstitution of the NADPH oxidase in a nonhematopoietic system. Blood 99, 2653 2661.
54. Raspe E., Duez H., Gervois P., Fievet C., Fruchart J. C., Besnard S., Mariani J., Tedgui A. Staels B. (2001) Transcriptional regulation of apolipoprotein C-III gene expression by the orphan nuclear receptor RORalpha. J. Biol. Chem. 276, 2865 2871.
55. Rochette-Egly C. (2003) Nuclear receptors: integration of multiple signalling pathways through phosphorylation. Cell. Signal. 15, 355 366.
56. Rubio I., Rennert K., Wittig U., Beer K., Durst M., Stang S. L., Stone J. Wetzker R. (2006) Ras activation in response to phorbol ester proceeds independently of the EGFR via an unconventional nucleotide-exchange factor system in COS-7 cells. Biochem. J. 398, 243 256.
57. Schonwasser D. C., Marais R. M., Marshall C. J. Parker P. J. (1998) Activation of the mitogen-activated protein kinase/extracellular signal-regulated kinase pathway by conventional, novel, and atypical protein kinase C isotypes. Mol. Cell. Biol. 18, 790 798.
58. Schrenk K., Kapfhammer J. P. Metzger F. (2002) Altered dendritic development of cerebellar Purkinje cells in slice cultures from protein kinase Cgamma-deficient mice. Neuroscience 110, 675 689.
59. Sidman R. L., Lane P. W. Dickie M. M. (1962) Staggerer, a new mutation in the mouse affecting the cerebellum. Science 137, 610 612.
60. Steinmayr M., Andre E., Conquet F. et al. (1998) Staggerer phenotype in retinoid-related orphan receptor alpha-deficient mice. Proc. Natl Acad. Sci. USA 95, 3960 3965.
61. Tanaka C. Saito N. (1992) Localization of subspecies of protein kinase C in the mammalian central nervous system. Neurochem. Int. 21, 499 512.
62. Toullec D., Pianetti P., Coste H. et al. (1991) The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C. J. Biol. Chem. 266, 15771 15781.
63. Verbeek D. S., Knight M. A., Harmison G. G., Fischbeck K. H. Howell B. W. (2005) Protein kinase C gamma mutations in spinocerebellar ataxia 14 increase kinase activity and alter membrane targeting. Brain 128, 436 442.
64. van de Warrenburg B. P., Verbeek D. S., Piersma S. J., Hennekam F. A., Pearson P. L., Knoers N. V., Kremer H. P. Sinke R. J. (2003) Identification of a novel SCA14 mutation in a Dutch autosomal dominant cerebellar ataxia family. Neurology 61, 1760 1765.
65. Wetsel W. C., Khan W. A., Merchenthaler I., Rivera H., Halpern A. E., Phung H. M., Negro-Vilar A. Hannun Y. A. (1992) Tissue and cellular distribution of the extended family of protein kinase C isoenzymes. J. Cell Biol. 117, 121 133.
66. Willaime S., Vanhoutte P., Caboche J., Lemaigre-Dubreuil Y., Mariani J. Brugg B. (2001) Ceramide-induced apoptosis in cortical neurons is mediated by an increase in p38 phosphorylation and not by the decrease in ERK phosphorylation. Eur. J. Neurosci. 13, 2037 2046.
67. Yabe I., Sasaki H., Chen D. H., Raskind W. H., Bird T. D., Yamashita I., Tsuji S., Kikuchi S. Tashiro K. (2003) Spinocerebellar ataxia type 14 caused by a mutation in protein kinase C gamma. Arch. Neurol. 60, 1749 1751.
68. Yamashita I., Sasaki H., Yabe I. et al. (2000) A novel locus for dominant cerebellar ataxia (SCA14) maps to a 10.2-cm interval flanked by D19S206 and D19S605 on chromosome 19q13.4-qter. Ann. Neurol. 48, 156 163.
69. Zanjani H. S., Mariani J., Delhaye-Bouchaud N. Herrup K. (1992) Neuronal cell loss in heterozygous staggerer mutant mice: a model for genetic contributions to the aging process. Brain Res. Dev. Brain Res. 67, 153 160.